Dr. Reddy’s Laboratories, along with its subsidiaries (together referred to as “Dr. Reddy’s”) announced the launch of Dr. Reddy’s Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar® (sorafenib) Tablets in the U.S. market, following the approval by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy’s Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.